These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, Guerra MR. Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226 [Abstract] [Full Text] [Related]
3. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE, Zierski M, Graczyk J, Bek E, Farer LS. Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281 [Abstract] [Full Text] [Related]
4. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029 [Abstract] [Full Text] [Related]
8. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin]. Suzuyama Y, Shigeno Y, Shigeno H, Nakazato H, Nagasawa M, Koga H, Tomita H, Tomonaga A, Yamaguchi K, Izumikawa K. Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457 [No Abstract] [Full Text] [Related]
9. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet; 1975 Jan 18; 1(7899):119-24. PubMed ID: 46047 [Abstract] [Full Text] [Related]
10. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec 18; 1(6):509-17. PubMed ID: 9487448 [Abstract] [Full Text] [Related]